TY - JOUR
T1 - Determining post-operative morbidity and mortality following gynecological oncology surgery
T2 - Protocol for a multicenter, international, prospective cohort study (Global Gynaecological Oncology Surgical Outcomes Collaborative - GO SOAR)
AU - Gaba, Faiza
AU - Bizzarri, Nicolò
AU - Kamfwa, Paul
AU - Saiz, Allison
AU - Blyuss, Oleg
AU - Paranjothy, Shantini
AU - Ramirez, Pedro T.
AU - Cibula, David
N1 - Publisher Copyright:
©
PY - 2021/9/1
Y1 - 2021/9/1
N2 - Background The Global Gynaecological Oncology Surgical Outcomes Collaborative (GO SOAR) aims to develop a network of gynecological oncology surgeons, surgical departments, and other interested parties that will have the long-term ability to collaborate on outcome studies. The protocol for the first collaborative study is presented here. Primary Objective To evaluate international variation in 30-day post-operative morbidity and mortality following gynecological oncology surgery between very high/high and medium/low human development index country settings. Hypothesis There is no variation in post-operative morbidity and mortality following gynecological oncology surgery between very high/high and medium/low human development index country settings. Study Design International, multicenter, prospective cohort study. Patient data will be collected over a consecutive 30-day period through gynecological oncology multidisciplinary teams/tumor boards and clinics across different human development index country groups. All data are collected on a customized, secure, password protected, central REDCap database. Major Inclusion/Exclusion Criteria Inclusion criteria include women aged ≥18 years undergoing elective/emergency, curative/palliative surgery for primary/recurrent tubo-ovarian/peritoneal, endometrial, cervical, vulval, vaginal, gestational trophoblastic malignancies. Surgical modality may be open, minimal access (laparoscopic/robotic), or vaginal. Primary Endpoint 30-day post-operative morbidity and mortality defined as per Clavien-Dindo classification system. Sample Size 1100 (550/arm). Estimated Dates for Completing Accrual and Presenting Results It is estimated recruitment will be completed by 2022 and results published by 2023. Trial Registration ClinicalTrials.gov registry: NCT04579861 (https://clinicaltrials.gov/ct2/show/NCT04579861).
AB - Background The Global Gynaecological Oncology Surgical Outcomes Collaborative (GO SOAR) aims to develop a network of gynecological oncology surgeons, surgical departments, and other interested parties that will have the long-term ability to collaborate on outcome studies. The protocol for the first collaborative study is presented here. Primary Objective To evaluate international variation in 30-day post-operative morbidity and mortality following gynecological oncology surgery between very high/high and medium/low human development index country settings. Hypothesis There is no variation in post-operative morbidity and mortality following gynecological oncology surgery between very high/high and medium/low human development index country settings. Study Design International, multicenter, prospective cohort study. Patient data will be collected over a consecutive 30-day period through gynecological oncology multidisciplinary teams/tumor boards and clinics across different human development index country groups. All data are collected on a customized, secure, password protected, central REDCap database. Major Inclusion/Exclusion Criteria Inclusion criteria include women aged ≥18 years undergoing elective/emergency, curative/palliative surgery for primary/recurrent tubo-ovarian/peritoneal, endometrial, cervical, vulval, vaginal, gestational trophoblastic malignancies. Surgical modality may be open, minimal access (laparoscopic/robotic), or vaginal. Primary Endpoint 30-day post-operative morbidity and mortality defined as per Clavien-Dindo classification system. Sample Size 1100 (550/arm). Estimated Dates for Completing Accrual and Presenting Results It is estimated recruitment will be completed by 2022 and results published by 2023. Trial Registration ClinicalTrials.gov registry: NCT04579861 (https://clinicaltrials.gov/ct2/show/NCT04579861).
KW - gynecologic surgical procedures
KW - postoperative complications
KW - surgical oncology
UR - http://www.scopus.com/inward/record.url?scp=85114695990&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85114695990&partnerID=8YFLogxK
U2 - 10.1136/ijgc-2021-002586
DO - 10.1136/ijgc-2021-002586
M3 - Article
C2 - 34489356
AN - SCOPUS:85114695990
SN - 1048-891X
VL - 31
SP - 1287
EP - 1291
JO - International Journal of Gynecological Cancer
JF - International Journal of Gynecological Cancer
IS - 9
ER -